Soluble cell adhesion molecules (sICAM‐1, sVCAM‐1, and sE‐selectin) in patients with early rheumatoid arthritis

References

• Nagase H., Okada Y. Proteinases and matrix degradation. Textbook of rheumatology, W. N Kelley, E. D Harris, S Ruddy, C. B Sledge. WB Saunders Company, Philadelphia 1997; 323–41
   Google Scholar
• Klimiuk P. A., Yang H. Goronzy JJ, Weyand CM. Production of cytokines and metalloproteinases in rheumatoid arthritis is T cell dependent. Clin Immunol 1999; 90: 65–78
   PubMed Web of Science ®Google Scholar
• Klimiuk P. A., Sierakowski S., Latosiewicz R., Cylwik B., Skowronski J., Chwiecko J. Serum metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid arthritis. Rheumatology (Oxford) 2002; 41: 78–87
   PubMed Web of Science ®Google Scholar
• Blann A. D., Herrick, Jayson M. I. V. Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis. Br J Rheumatol 1995; 34: 814–19
   PubMedGoogle Scholar
• Mojcik C. F., Shevach E. M. Adhesion molecules. A rheumatologic perspective. Arthritis Rheum 1997; 40: 991–1004
   PubMed Web of Science ®Google Scholar
• Tokuhira M., Hosaka S., Volin M. V., Haines G. K 3rd., Katschke K. J Jr., Kim S., et al. Soluble vascular cell adhesion molecule 1 mediation of monocyte chemotaxis in rheumatoid arthritis. Arthritis Rheum 2000; 43: 1122–33
   PubMed Web of Science ®Google Scholar
• Klimiuk P. A., Sierakowski S., Latosiewicz R., Cylwik J. P., Cylwik B., Skowronski J., et al. Soluble adhesion molecules (ICAM‐1, VCAM‐1, and E‐selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. Ann Rheum Dis 2002; 61: 804–9
   PubMed Web of Science ®Google Scholar
• Volin M. V. Soluble adhesion molecules in the pathogenesis of rheumatoid arthritis. Curr Pharm Des 2005; 11: 633–53
   PubMed Web of Science ®Google Scholar
• Paleolog E. M. Angiogenesis: a critical process in the pathogenesis of RA – a role for VEGF?. Br J Rheumatol 1996; 35: 917–20
   PubMedGoogle Scholar
• Brenchley P. E. C. Antagonising angiogenesis in rheumatoid arthritis. Ann Rheum Dis 2001; 60: iii71–4
   PubMed Web of Science ®Google Scholar
• Koch A. E., Halloran M. M., Haskell C. J., Shah M. R., Polverini P. J. Angiogenesis mediated by soluble forms of E‐selectin and vascular cell adhesion molecule‐1. Nature 1995; 376: 517–19
   PubMed Web of Science ®Google Scholar
• Kuuliala A., Eberhardt K., Takala A., Kautiainen H., Repo H., Leirisalo‐Repo M. Circulating soluble E‐selectin in early rheumatoid arthritis: a prospective five year study. Ann Rheum Dis 2002; 61: 242–6
   PubMedGoogle Scholar
• Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• Steinbrocker O., Traeger C. H., Batterman R. C. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc 1949; 140: 659–62
   PubMed Web of Science ®Google Scholar
• Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968; 37: 93–406
   Google Scholar
• van der Heijde D. M. F. M., van ‘t Hof M. A., van Riel P. L. C. M., Theunisse L. A. M., Lubberts E. W., van Leeuwen M. A., et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990; 49: 916–20
   PubMed Web of Science ®Google Scholar
• Tak P. P., Thurkow E. W., Daha M. R., Kluin P. M., Smeets T. J. M., Meinders A. E., et al. Expression of adhesion molecules in early rheumatoid synovial tissue. Clin Immunol Immunopathol 1995; 77: 236–42
   PubMedGoogle Scholar
• Mason J. C., Kapahi P., Haskard D. O. Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Arthritis Rheum 1993; 36: 519–27
   PubMed Web of Science ®Google Scholar
• Carter R. A., Wicks I. P. Vascular cell adhesion molecule 1 (CD106). A multifaceted regulator of joint inflammation. Arthritis Rheum 2001; 44: 985–94
   PubMed Web of Science ®Google Scholar
• Klimiuk P. A., Sierakowski S., Domyslawska I., Fiedorczyk M., Chwiecko J. Reduction of soluble adhesion molecules (sICAM‐1, sVCAM‐1, and sE‐selectin) and vascular endothelial growth factor levels in serum of rheumatoid arthritis patients following multiple intravenous infusions of infliximab. Arch Immunol Ther Exp 2004; 52: 36–42
   PubMed Web of Science ®Google Scholar
• Wallberg‐Jonsson S., Ohman M., Rantapaa‐Dahlqvist S. Which factors are related to the presence of atherosclerosis in rheumatoid arthritis?. Scand J Rheumatol 2004; 33: 373–9
   PubMed Web of Science ®Google Scholar
• Kuryliszyn‐Moskal A., Bernacka K., Klimiuk P. A. Circulating intercellular adhesion molecule 1 in rheumatoid arthritis – relationship to systemic vasculitis and microvascular injury in nailfold capillary microscopy. Clin Rheumatol 1996; 15: 367–73
   PubMed Web of Science ®Google Scholar
• Littler A. J., Buckley C. D., Wordsworth P., Collins I., Martinson J., Simmons D. L. A distinct profile of six soluble adhesion molecules (ICAM‐1, ICAM‐3, VCAM‐1, E‐selectin, L‐selectin and P‐selectin) in rheumatoid arthritis. Br J Rheumatol 1997; 36: 164–9
   PubMedGoogle Scholar
• Veale D. J., Maple C., Kirk G., McLaren M., Belch J. J. F. Soluble cell adhesion molecules – P‐selectin and ICAM‐1, and disease activity in patients receiving sulphasalazine for active rheumatoid arthritis. Scand J Rheumatol 1998; 27: 296–9
   PubMedGoogle Scholar
• Nassonov E. L., Samsonov M. Y., Chichasova N. V., Nikiphorova E. L., Tilz G. P., Demel U., et al. Soluble adhesion molecules in rheumatoid arthritis. Rheumatology (Oxford) 2000; 39: 808–10
   PubMed Web of Science ®Google Scholar
• Bloom B. J., Nelson S. M., Alario A. J., Miller L. C., Schaller J. G. Synovial fluid levels of E‐selectin and intercellular adhesion molecule‐1: relationship to joint inflammation in children with chronic arthritis. Rheumatol Int 2002; 22: 175–7
   PubMedGoogle Scholar
• To S. S. T., Newman P. M., Hyland V. J., Robinson B. G., Schrieber L. Regulation of adhesion molecule expression by human synovial microvascular endothelial cells in vitro. Arthritis Rheum 1996; 39: 467–77
   PubMed Web of Science ®Google Scholar
• Ferrara N. Leukocyte adhesion. Missing link in angiogenesis. Nature 1995; 376: 467
   PubMed Web of Science ®Google Scholar
• Voskuyl A. E., Martin S., Melchers I., Zwinderman A. H., Weichselbraun I., Breedveld F. C. Levels of circulating intercellular adhesion molecule‐1 and ‐3 but not circulating endothelial leucocyte adhesion molecule are increased in patients with rheumatoid vasculitis. Br J Rheumatol 1995; 34: 311–15
   PubMedGoogle Scholar
• af Klint E., Grundtman C., Engstrom M., Catrina A. I., Makrygiannakis D., Klareskog L., et al. Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels. Arthritis Rheum 2005; 52: 3880–9
   PubMed Web of Science ®Google Scholar